 |
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
,§
*
Pathology, Massachusetts General Hospital and Harvard Medical School,
Boston, Massachusetts.
Surgery, Massachusetts General Hospital and Harvard Medical School,
Boston, Massachusetts.
||
Medicine Services, Massachusetts General Hospital and Harvard Medical
School, Boston, Massachusetts.
Immunopathology, Massachusetts General Hospital and Harvard Medical
School, Boston, Massachusetts.
§
Transplantation Units, Massachusetts General Hospital and Harvard Medical
School, Boston, Massachusetts.
Correspondence to Dr. Shamila Mauiyyedi, Warren 225, Department of Pathology, Massachusetts General Hospital, Boston, MA 02140. Phone: 617-726-2966; Fax: 617-726-7533; E-mail: smauiyyedi{at}partners.org
Abstract. The pathogenesis of chronic renal allograft rejection (CR) remains obscure. The hypothesis that a subset of CR is mediated by antidonor antibody was tested by determining whether C4d is deposited in peritubular capillaries (PTC) and whether it correlates with circulating antidonor antibodies. All cases (from January 1, 1990, to July 31, 1999) that met histologic criteria for CR and had frozen tissue (28 biopsies, 10 nephrectomies) were included. Controls were renal allograft biopsies with chronic cyclosporine toxicity (n = 21) or nonspecific interstitial fibrosis (n = 10), and native kidneys with end-stage renal disease (n = 10) or chronic interstitial fibrosis (n = 5). Frozen sections were stained by two-color immunofluorescence for C4d, type IV collagen and Ulex europaeus agglutinin I. Antidonor HLA antibody was sought by panel-reactive antibody analysis and/or donor cross matching in sera within 7 wk of biopsy. Overall, 23 of 38 CR cases (61%) had PTC staining for C4d, compared with 1 of 46 (2%) of controls (P < 0.001). C4d in PTC was localized at the interface of endothelium and basement membrane. Most of the C4d-positive CR tested had antidonor HLA antibody (15 of 17; 88%); none of the C4d-negative CR tested (0 of 8) had antidonor antibody (P < 0.0002). The histology of C4d-positive CR was similar to C4d-negative CR, and 1-yr graft survival rates were 62% and 25%, respectively (P = 0.05). Since August 1998, five of six C4d-positive CR cases have been treated with mycophenolate mofetil ± tacrolimus with a 100% 1-yr graft survival, versus 40% before August 1998 (P < 0.03). These data support the hypothesis that a substantial fraction of CR is mediated by antibody (immunologically active). C4d can be used to separate this group of CR from the nonspecific category of chronic allograft nephropathy and may have the potential to guide successful therapeutic intervention.
This article has been cited by other articles:
 |
|
 |
|
  J. Ashton-Chess, M. Giral, M. Mengel, K. Renaudin, Y. Foucher, W. Gwinner, C. Braud, E. Dugast, T. Quillard, P. Thebault, et al. Tribbles-1 as a Novel Biomarker of Chronic Antibody-Mediated Rejection J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1116 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ranjan, R. Nada, V. Jha, V. Sakhuja, and K. Joshi The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1735 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pascual, M. D. Samaniego, J. R. Torrealba, J. S. Odorico, A. Djamali, Y. T. Becker, B. Voss, G. E. Leverson, S. J. Knechtle, H. W. Sollinger, et al. Antibody-Mediated Rejection of the Kidney after Simultaneous Pancreas-Kidney Transplantation J. Am. Soc. Nephrol., April 1, 2008; 19(4): 812 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Jevnikar and R. B. Mannon Late Kidney Allograft Loss: What We Know about It, and What We Can Do about It Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S56 - S67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Akalin, R. Dinavahi, S. Dikman, G. de Boccardo, R. Friedlander, B. Schroppel, V. Sehgal, J. S. Bromberg, P. Heeger, and B. Murphy Transplant Glomerulopathy May Occur in the Absence of Donor-Specific Antibody and C4d Staining Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1261 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Racusen Chronic Transplant Glomerulopathy: Need for Further Assessment Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1108 - 1109. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, L. Ma, J. Shen, and A. S. Chong Peripheral deletion of mature alloreactive B cells induced by costimulation blockade PNAS, July 17, 2007; 104(29): 12093 - 12098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Colvin Antibody-Mediated Renal Allograft Rejection: Diagnosis and Pathogenesis J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1046 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kambham, S. Nagarajan, S. Shah, L. Li, O. Salvatierra, and M. M. Sarwal A Novel, Semiquantitative, Clinically Correlated Calcineurin Inhibitor Toxicity Score for Renal Allograft Biopsies Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Racusen and M. Haas Antibody-Mediated Rejection in Renal Allografts: Lessons from Pathology Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 415 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Troxell, L. A. Weintraub, J. P. Higgins, and N. Kambham Comparison of C4d Immunostaining Methods in Renal Allograft Biopsies Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 583 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Mannon and A. D. Kirk Beyond Histology: Novel Tools to Diagnose Allograft Dysfunction Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 358 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Tinckam and A. Chandraker Mechanisms and Role of HLA and non-HLA Alloantibodies Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 404 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Braun, D. M. Stablein, L. A. Hamiwka, L. Bell, S. M. Bartosh, and C. F. Strife Recurrence of Membranoproliferative Glomerulonephritis Type II in Renal Allografts: The North American Pediatric Renal Transplant Cooperative Study Experience J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2225 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sund, P. Grimm, A. V. Reisaeter, and T. Hovig Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2838 - 2845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Poggio, M. Clemente, J. Riley, M. Roddy, N. S. Greenspan, C. Dejelo, N. Najafian, M. H. Sayegh, D. E. Hricik, and P. S. Heeger Alloreactivity in Renal Transplant Recipients with and without Chronic Allograft Nephropathy J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1952 - 1960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Colvin Chronic Allograft Nephropathy N. Engl. J. Med., December 11, 2003; 349(24): 2288 - 2290. [Full Text] [PDF]
|
|
|
|
|
|
V. Nickeleit and M. J. Mihatsch Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2232 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nakashima, Z. Qian, S. Rahimi, B. A. Wasowska, and W. M. Baldwin III Membrane Attack Complex Contributes to Destruction of Vascular Integrity in Acute Lung Allograft Rejection J. Immunol., October 15, 2002; 169(8): 4620 - 4627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Regele, G. A. Bohmig, A. Habicht, D. Gollowitzer, M. Schillinger, S. Rockenschaub, B. Watschinger, D. Kerjaschki, and M. Exner Capillary Deposition of Complement Split Product C4d in Renal Allografts is Associated with Basement Membrane Injury in Peritubular and Glomerular Capillaries: A Contribution of Humoral Immunity to Chronic Allograft Rejection J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2371 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Watschinger and M. Pascual Capillary C4d Deposition as a Marker of Humoral Immunity in Renal Allograft Rejection J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2420 - 2423. [Full Text] [PDF]
|
|
|
|
|
|
S. Mauiyyedi, M. Crespo, A. B. Collins, E. E. Schneeberger, M. A. Pascual, S. L. Saidman, N. E. Tolkoff-Rubin, W. W. Williams, F. L. Delmonico, A. B. Cosimi, et al. Acute Humoral Rejection in Kidney Transplantation: II. Morphology, Immunopathology, and Pathologic Classification J. Am. Soc. Nephrol., March 1, 2002; 13(3): 779 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pascual, T. Theruvath, T. Kawai, N. Tolkoff-Rubin, and A. B. Cosimi Strategies to Improve Long-Term Outcomes after Renal Transplantation N. Engl. J. Med., February 21, 2002; 346(8): 580 - 590. [Full Text] [PDF]
|
|
|
|
|
|
V. Nickeleit, M. Zeiler, F. Gudat, G. Thiel, and M. J. Mihatsch Detection of the Complement Degradation Product C4d in Renal Allografts: Diagnostic and Therapeutic Implications J. Am. Soc. Nephrol., January 1, 2002; 13(1): 242 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Baker, M. P. Hernandez-Fuentes, P. A. Brookes, A. N. Chaudhry, H. T. Cook, and R. I. Lechler Loss of Direct and Maintenance of Indirect Alloresponses in Renal Allograft Recipients: Implications for the Pathogenesis of Chronic Allograft Nephropathy J. Immunol., December 15, 2001; 167(12): 7199 - 7206. [Abstract] [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
